Brimonidine Tartrate Ophthalmic Solution, 0.1% is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure
Also received tentative approval for 137 mg
Bortezomib Injection is approved for subcutaneous or intravenous use. It is available as a single dose vial of 3.5 mg/1.4 mL (2.5 mg/mL)
The new bioeconomy policy rolled out by the Modi government is set to place India as a global leader in the years to come
Ordspono is Regeneron’s first approved bispecific antibody and will provide an off-the-shelf option that can be administered in the out-patient setting, with hope for complete remission
The grant is designated for the research and development of Pyronaridine
PiaSky advances C5 inhibition through innovative recycling technology, which enables its monthly SC administration
e brings over 27+ years of rich pharmaceutical experience
Honeywell Quality Management Review helps manufacturers boost efficiency and quality compliance
The JV will establish a state-of-the-art manufacturing facility to manufacture fermented animal free protein to cater to the global markets
Subscribe To Our Newsletter & Stay Updated
